Publication:
The inhibition of PI3K and NF kappa B promoted curcumin-induced cell cycle arrest at G2/M via altering polyamine metabolism in Bcl-2 overexpressing MCF-7 breast cancer cells

dc.contributor.authorAkkoç, Yunus
dc.contributor.authorÇoker Gürkan, Ajda
dc.contributor.authorPalavan Ünsal, Zeynep Narçın
dc.contributor.authorBerrak, Özge
dc.contributor.authorARISAN, ELİF DAMLA
dc.contributor.authorYERLİKAYA, PINAR OBAKAN
dc.contributor.authorID113920tr_TR
dc.contributor.authorID125860tr_TR
dc.contributor.authorID156421tr_TR
dc.contributor.authorID6125tr_TR
dc.date.accessioned2018-07-19T07:49:56Z
dc.date.available2018-07-19T07:49:56Z
dc.date.issued2016-02
dc.description.abstractBcl-2 protein has been contributed with number of genes which are involved in oncogenesis. Among the many targets of Bcl-2, NF kappa B have potential role in induction of cell cycle arrest. Curcumin has potential therapeutic effects against breast cancer through multiple signaling pathways. In this study, we investigated the role of curcumin in induction of cell cycle arrest via regulating of NF kappa B and polyamine biosynthesis in wt and Bcl-2+ MCF-7 cells. To examine the effect of curcumin on cell cycle regulatory proteins, PI3K/Akt, NF kappa B pathways and polyamine catabolism, we performed immunoblotting assay. In addition, cell cycle analysis was performed by flow cytometry. The results indicated that curcumin induced cell cycle arrest at G2/M phase by downregulation of cyclin B1 and Cdc2 and inhibited colony formation in MCF-7 wt cells. However, Bcl-2 overexpression prevented the inhibition of cell cycle associated proteins after curcumin treatment. The combination of LY294002, PI3K inhibitor, and curcumin induced cell cycle arrest by decreasing CDK4, CDK2 and cyclin E2 in Bcl-2+ MCF-7 cells. Moreover, LY294002 further inhibited the phosphorylation of Akt in Bcl-2+ MCF-7 cells. Curcumin could suppress the nuclear transport of NF kappa B through decreasing the interaction of P-I kappa B-NF kappa B. The combination of wedelolactone, NF kappa B inhibitor, and curcumin acted different on SSAT expression in wt MCF-7 and Bcl-2+ MCF-7 cells. NF kappa B inhibition increased the SSAT after curcumin treatment in Bcl2 overexpressed MCF-7 cells. Inhibition of NF kappa B activity as well as suppression of ROS generation with NAC resulted in the partial relief of cells from G2/M checkpoint after curcumin treatment in wt MCF7 cells. In conclusion, the potential role of curcumin in induction of cell cycle arrest is related with NF kappa B-regulated polyamine biosynthesis. (C) 2015 Elsevier Masson SAS. All rights reserved.tr_TR
dc.identifier.issn0753-3322
dc.identifier.other1950-6007
dc.identifier.pubmed26796279
dc.identifier.pubmed26796279en
dc.identifier.urihttps://doi.org/10.1016/j.biopha.2015.12.007
dc.identifier.urihttps://hdl.handle.net/11413/2197
dc.identifier.wos368104100023
dc.identifier.wos368104100023en
dc.language.isoen_UStr_TR
dc.publisherElsevier France-Editions Scientifiques Medicales Elsevier, 23 Rue Linois, 75724 Paris, Francetr_TR
dc.relationBiomedicine & Pharmacotherapytr_TR
dc.subjectCurcumintr_TR
dc.subjectCell cycletr_TR
dc.subjectBcl-2tr_TR
dc.subjectNF kappa Btr_TR
dc.subjectPhosphatidylinositol 3-Kinasetr_TR
dc.subjectTargeting Bcl-2tr_TR
dc.subjectInduced Apoptosistr_TR
dc.subjectPathwaytr_TR
dc.subjectGrowthtr_TR
dc.subjectActivationtr_TR
dc.subjectExpressiontr_TR
dc.subjectProliferationtr_TR
dc.subjectD1tr_TR
dc.subjectPhosphorylationtr_TR
dc.titleThe inhibition of PI3K and NF kappa B promoted curcumin-induced cell cycle arrest at G2/M via altering polyamine metabolism in Bcl-2 overexpressing MCF-7 breast cancer cellstr_TR
dc.typeArticle
dspace.entity.typePublication
local.indexed.atpubmed
local.indexed.atwos
relation.isAuthorOfPublication3d33e154-a50c-46b8-ad6e-25a26bf11cf0
relation.isAuthorOfPublication387670e2-5a88-4937-b3da-1dda9aedfbdd
relation.isAuthorOfPublication.latestForDiscovery3d33e154-a50c-46b8-ad6e-25a26bf11cf0

Files

License bundle

Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description: